Hammer, H. B., Fagerhol, M. K., Wien, T. N., & Kvien, T. K. (2011). The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab. BioMed Central.
Chicago Style CitationHammer, Hilde Berner, Magne K. Fagerhol, Tale Norbye Wien, and Tore K. Kvien. The Soluble Biomarker Calprotectin (a S100 Protein) Is Associated to Ultrasonographic Synovitis Scores and Is Sensitive to Change in Patients With Rheumatoid Arthritis Treated With Adalimumab. BioMed Central, 2011.
MLA CitationHammer, Hilde Berner, Magne K. Fagerhol, Tale Norbye Wien, and Tore K. Kvien. The Soluble Biomarker Calprotectin (a S100 Protein) Is Associated to Ultrasonographic Synovitis Scores and Is Sensitive to Change in Patients With Rheumatoid Arthritis Treated With Adalimumab. BioMed Central, 2011.